Screening for pre-hypertension and elevated cardiovascular risk factors in a Thai community pharmacy

ISSN： 0928-1231

Source： Pharmacy World and Science, Vol.32, Iss.3, 2010-06, pp. : 329-333

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiovascular risk screening program in Australian community pharmacies

By Peterson Gregory

Pharmacy World and Science, Vol. 32, Iss. 3, 2010-06 ,pp. : 373-380

Springer Publishing Company

Access to resources Recommend Favorite

Screening for cardiovascular and renal risk factors with subsequent intervention letter is effective in terms of increasing drug treatment for hypertension and/or hyperlipidaemia, but is "definitely not optimal"

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 452, 2004-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Relationship Between Hematocrit Level and Cardiovascular Risk Factors in a Community‐Based Population

Journal Of Clinical Laboratory Analysis (Electronic), Vol. 29, Iss. 4, 2015-07 ,pp. : 289-293

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of the Thiazolidinediones on Cardiovascular Risk Factors

By Gilling L. Suwattee P. DeSouza C. Asnani S. Fonseca V.

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 3, 2002-01 ,pp. : 149-156

Adis International

Access to resources Recommend Favorite

Treatment of Cardiovascular Risk Factors in Women

Current Medicinal Chemistry, Vol. 22, Iss. 31, 2015-10 ,pp. : 3580-3596

Bentham Science Publishers

Access to resources Recommend Favorite